Inventor
SATOH MITSUO
JP29 patents
⚠️ This page may combine multiple inventors who share the name “SATOH MITSUO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KYOWA HAKKO KIRIN CO LTD
12 patentsUS7737325B2Jun 15, 2010
Antibody composition-producing cell
KYOWA HAKKO KIRIN CO LTD55 citations99
US7749753B2Jul 6, 2010
Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost
KYOWA HAKKO KIRIN CO LTD53 citations98
US7846725B2Dec 7, 2010
Antibody composition-producing cell in which enzyme expression is inhibited by RNAi
KYOWA HAKKO KIRIN CO LTD35 citations96
US7741442B2Jun 22, 2010
Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation
KYOWA HAKKO KIRIN CO LTD32 citations96
US8039595B2Oct 18, 2011
Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation
KYOWA HAKKO KIRIN CO LTD9 citations93
US7691810B2Apr 6, 2010
Method of producing recombinant antithrombin III composition
KYOWA HAKKO KIRIN CO LTD26 citations92
US8895266B2Nov 25, 2014
Antibody composition-producing cell
KYOWA HAKKO KIRIN CO LTD4 citations84
US10233475B2Mar 19, 2019
Antibody composition-producing cell
KYOWA HAKKO KIRIN CO LTD0 citations63
US9409982B2Aug 9, 2016
Antibody composition-producing cell
KYOWA HAKKO KIRIN CO LTD0 citations63
US8367407B2Feb 5, 2013
Cells with altered fucosylation and producing antibodies therefrom
KYOWA HAKKO KIRIN CO LTD0 citations63
US7858091B2Dec 28, 2010
Antibodies to insulin-like growth factor binding protein and uses thereof
KYOWA HAKKO KIRIN CO LTD2 citations62
US8361751B2Jan 29, 2013
Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost
KYOWA HAKKO KIRIN CO LTD0 citations52
KANDA YUTAKA
6 patentsUS8067232B2Nov 29, 2011
Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase
KANDA YUTAKA45 citations97
US8101185B2Jan 24, 2012
Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation
KANDA YUTAKA6 citations92
US8329443B2Dec 11, 2012
Antibody composition-producing cell
KANDA YUTAKA4 citations73
US8158760B2Apr 17, 2012
Glycoengineered, recombinant antibody
KANDA YUTAKA4 citations73
US8110195B2Feb 7, 2012
Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody
KANDA YUTAKA4 citations73
US8501914B2Aug 6, 2013
Recombinant protein S composition
KANDA YUTAKA4 citations62
KYOWA HAKKO KOGYO KK
5 patentsUS7425446B2Sep 16, 2008
Antibody composition-producing cell
KYOWA HAKKO KOGYO KK93 citations99
US7393683B2Jul 1, 2008
Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferase
KYOWA HAKKO KOGYO KK63 citations99
US6946292B2Sep 20, 2005
Cells producing antibody compositions with increased antibody dependent cytotoxic activity
KYOWA HAKKO KOGYO KK566 citations99
US7071160B2Jul 4, 2006
Insulin-like growth factor-binding protein
KYOWA HAKKO KOGYO KK15 citations92
US7332301B2Feb 19, 2008
Insulin-like growth factor binding protein
KYOWA HAKKO KOGYO KK0 citations51